Tetramed Holdings Corporation Expanding Board of Directors with Cannabis Industry Leaders
Summary
In addition to performing medical cannabis patient recommendations as part of his patient care programs, Dr. Soler’s work as a Primary Study Investigator for Pfizer and Merck Pharmaceuticals, serving on Rush Prudential Pharmacy and Therapeutics Committee, Advocate Healthcare Credentialing Committee, Resurrection Healthcare Preferred Board of Directors, Board of Director for CannabisIsMedicina, and Medical Advisor for Accretive Healthcare brings a unique perspective on Tetramed’s ongoing pursuit of the highest quality cannabis across all facets of the industry.His commitment and impact on the lives of his patients and the national medical community bring great balance and perspective to our board,” commented Dan Caravette, CEO of Tetramed Holdings Corporation, Inc.Las Vegas, NV, December 30, 2016 --( PR.com )-- Nevada based Tetramed Holdings Corporation, parent company of Sin City Cultivation Inc., has recently announced two additions to their board of directors.On the heels of Novembers successful statewide referendum on recreational cannabis legalization, accomplished attorney and industry advocate Michael A.Fine, and physician Dr. Fernando Soler join the Tetramed Holdings Corporation Board of Directors.An attorney and mortgage company owner by profession, Michael A.